Login / Signup

Quantitative p53 immunostaining aids in the detection of prevalent dysplasia.

Vikram DeshpandeSteffen RickeltOmer H YilmazPaige H ParrackChenyue LuOsman YilmazElizabeth Y WuWon-Tak ChoiManish GalaDavid T TingRobert D OdzeDeepa T PatilVikram Deshpande
Published in: Journal of clinical pathology (2023)
Automated p53 analysis in NDBE biopsies serves as a promising tool for assessing BE neoplastic progression and risk stratification. Our study highlights the practical applicability of p53 assay to routine surveillance practice and its ability to detect prevalent dysplasia.
Keyphrases